Children’s cough syrup recalled due to overdose risk

Some of the children's cough medicine brands being recalled by Perrigo.

(NBC) — Perrigo Company said Monday it’s recalling two flavors of its children’s liquid cough medicine because of a potential overdose risk.

The recall includes two batches of children’s guaifenesin grape liquid (100mg/5 mL) and three batches of children’s guaifenesin DM cherry liquid (100mg guaifenesin and 5mg dextromethorphan HBr/ 5 ml) sold in 4 oz. bottles with the dosage cup in a box. The medicine is being sold nationwide under a variety of brand names, including Rite-Aid, Dollar General, CVS and Kroger. See product labels here.

Take a look at the chart below or click here to check the recalled lots, along with their corresponding branded labels:

Guaifenesin Cherry Liquid 4 OZ

Label Lot number Expiration
Sunmark 5LK0528, 5LK0630 3/1/2017
Rite-Aid 5LK0528, 5LK0630 3/1/2017
Topcare 5LK0528, 5LK0630, 5LK0779 3/1/2017
Kroger 5LK0528, 5LK0630 3/1/2017
GoodSense 5LK0528 3/1/2017
Dollar General 5LK0630 3/1/2017
Care One 5LK0630 3/1/2017
CVS 5LK0630 3/1/2017

Guaifenesin Grape Liquid 4 OZ

Label Lot number Expiry
H.E.B 5LK0592 8/1/2017
CVS 5MK0340 8/1/2017

The company said in a press release that it issued the recall because some packages contain an oral dosing cup with incorrect dose markings. Perrigo said there have been “no reports of adverse events” to the syrup as a result of the incorrect dosage markings.

An overdose of Guaifenesin DM may cause hyper excitability, rapid eye movements, changes in muscle reflexes, ataxia, dystonia, hallucinations, stupor, and coma, the Perrigo statement said. It said nausea, vomiting, tachycardia, irregular heartbeat, seizures, respiratory depression, and death can also occur with overdose.

Consumers who purchased the product should discard the dosing device and product and may call Perrigo, toll free, Monday through Friday from 8:00 a.m. to 10 p.m. ET at 1-888-345-0479, or visit mucusreliefrecall.com.

WFLA.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others and keep the conversation on topic and civil. If you see an inappropriate comment, please flag it for our moderators to review.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s